Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Merck Names China Expert as Directory of Strategy

publication date: Sep 28, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Merck, known as MSD outside the United States and Canada, selected a member of WuXi PharmaTech’s board of directors to be its own Chief Strategy Director. Cuong Viet Do has experience in both healthcare and M&A, in addition to familiarity with China business. From 1989 to 2006, Do was a director and senior partner at McKinsey & Company, where he worked in global healthcare and then high-tech/corporate finance in China and Asia. Because of his extensive experience in Asia, Do’s appointment underscores the significance of China and Asia to Merck. More details....

Stock Symbols: (NYSE: MRK) (NYSE: WX)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...